Cell Bridge Strategies Revenue and Competitors
Estimated Revenue & Valuation
- Cell Bridge Strategies's estimated annual revenue is currently $775k per year.
- Cell Bridge Strategies's estimated revenue per employee is $155,000
Employee Data
- Cell Bridge Strategies has 5 Employees.
- Cell Bridge Strategies grew their employee count by 0% last year.
Cell Bridge Strategies's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
Cell Bridge Strategies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Cell Bridge Strategies?
Cell Bridge Strategies is a growing Life Science consulting firm that helps “Executives match their Scientific and Business Objectives with Market Demandâ€. We are unique because we have both, strong Life Science and deep business acumen. Our team gives us flexibility, agility, and expanded capabilities so that we can address numerous aspects of your business at once: Our fractional CEO, CFO, COO, and Sales services can be used to help you create forward-looking corporate and financial strategies based on the science, commercial potential, and the markets; partnering / M&A considerations as well as transnational strategies and IND/FDA filing support can be provided.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 7 | -83% | N/A |
#2 | $1.1M | 8 | 0% | N/A |
#3 | $1M | 11 | -31% | N/A |
#4 | $2.4M | 15 | 0% | N/A |
#5 | N/A | 22 | -75% | N/A |